New platform aims to predict cancer risk and detect return before symptoms
NCT ID NCT07469709
First seen Mar 16, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study is building a platform to better understand a person's risk of developing cancer or having it come back. Researchers will analyze blood samples from 850 people with certain cancers to find genetic markers, immune system changes, and other biological clues. The goal is to catch cancer or its return earlier, before it shows up on scans or causes symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
RECRUITINGCandiolo, Turin, 10060, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.